Mounjaro

Mounjaro is a prescription-only, FDA-approved injectable medication used with exercise and a diet to significantly improve blood sugar levels (A1C) in adults with type 2 diabetes mellitus. This once-weekly injectable medication is approved only for adults and children aged 10 years. The safety of Mounjaro in children under 10 years of age has not been established. Remember that Mounjaro is not FDA-approved for weight loss.

Quick Facts About Mounjaro

Mounjaro is FDA-approved to:

• Improve blood sugar level in people with type 2 diabetes mellitus.

Mounjaro is available in multiple dosage strengths, allowing treatment to be adjusted as your needs change. Your healthcare provider may do these Mounjaro dosage adjustments. Below is a brief summary of the available options:

When you consider Mounjaro for type 2 diabetes, follow these administration guidelines:

• Carefully read the Mounjaro Guide and the KwikPen instructions before your first dose.
• Take Mounjaro once a week, at any time of day, with or without food.
• Check the medicine before using the KwikPen. It should be clear and colorless to slightly yellow. Do not use it if you see particles or any color change.
• If the medication has been stored in the refrigerator, let it reach room temperature before using.
• Inject it under the skin in the thigh, stomach area, or upper arm.
• Use a different injection spot each time to avoid skin irritation.
• If you also use insulin, give Mounjaro as a separate injection and never combine it with insulin.
• If you miss a Mounjaro dose, take it as soon as possible within 4 days (96 hours). If more than four days have passed, skip the missed Mounjaro dose and resume your regular schedule.
• If you take too much Mounjaro, contact your healthcare provider or the poison control center immediately. Mounjaro overdose may cause severe nausea, vomiting, or low blood sugar.

Unlike older diabetes medications, Mounjaro works by activating two receptors, GLP-1 and GIP, which increase the body's incretin hormones. These hormones help your body release more insulin when needed, reduce the amount of sugar produced by the liver, and slow digestion so sugar enters the blood more gradually.

Many individuals experience Mounjaro side effects for only a week, while others may take several weeks or longer to fully adjust.

Mounjaro Boxed Warning: Risk of Thyroid C-Cell Tumors

Mounjaro has a boxed warning because of a potential risk of thyroid C-cell tumors. In animal studies, tirzepatide and other similar medications caused thyroid C-cell tumors in rats. It is not known whether this risk applies to humans, including the risk of medullary thyroid carcinoma (MTC).

Patients should quickly inform their healthcare provider if they notice symptoms such as a lump or swelling in the neck, difficulty swallowing, shortness of breath, or hoarseness, as these may indicate thyroid cancer.

• Mounjaro is not used for patients with type 1 diabetes or those with a history of pancreatitis.
• Before starting Mounjaro, tell your doctor about:
  • All medicines you are taking
  • Health conditions and allergies
  • Pregnancy or breastfeeding
  • Low blood sugar may occur, especially if you use Mounjaro with insulin or other diabetes medicines.
• Mounjaro may increase the risk of gallbladder problems.
• Kidney problems, including sudden kidney damage, can occur in some patients.
• If you have had diabetic eye disease, your doctor should monitor your eyes for any worsening during treatment.

Mounjaro may interact with several medications. Some of the main Mounjaro interactions are listed below:

• Insulin
• Sulfonylureas (e.g., glimepiride, gliclazide, glipizide)
• Certain Oral Medications
• Oral Contraceptives (ethinyl estradiol-containing products)

Mounjaro alternatives include:

• Zepbound (tirzepatide)
• Ozempic (semaglutide)
• Wegovy (semaglutide)
• Rybelsus (semaglutide)
• Victoza (liraglutide)
• Trulicity (dulaglutide)
• Metformin
• Januvia (sitagliptin)

When researchers evaluated treatment options for adults living with type 2 diabetes, Mounjaro and Ozempic were studied side by side. One major clinical trial followed nearly 1,900 adults over 40 weeks. During the trial, three doses of Mounjaro were evaluated and compared with a standard 1 mg dose of Ozempic. Here are the results:

Buying Mounjaro online from Polar Bear Meds is a smart way to save money without sacrificing quality. With the average cost of Mounjaro for type 2 diabetes in the U.S. reaching around $1,580, it can feel overwhelming for you to buy this medication. However, with us, you can save between $924.04 and $1,421.01. Plus, we connect you with licensed Canadian pharmacies so you can access authentic Mounjaro (tirzepatide) at prices up to 80% lower than U.S. pharmacies. To make it even better, first-time customers can get an extra 10% off by using the Mounjaro coupon code “WELCOMEPB10” at checkout.

All medicines are sourced from licensed Canadian pharmacies and shipped securely to your home in the United States. The process is simple, delivery is fast, and most Mounjaro orders arrive within 3-5 business days. To get started, contact us at 1-888-779-2193 for assistance.

• https://mounjaro.lilly.com/
• https://www.drugs.com/mounjaro.html
• https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866s000lbl.pdf
• https://mounjaro.lilly.com/what-is-mounjaro/t2d-competitors